Faber Daeufer Itrato & Cabot provides corporate and transactional counsel to clients in the drug and life sciences industries, and in other emerging technology sectors including cleantech and cloud computing.
The driving force of our practice is our focus on the business transactions that accelerate company growth, and scientific product development and commercialization, from the discovery and invention phase through commercial success. Our deep legal expertise, especially in life sciences, cleantech and other technology-related matters, yields extraordinary creative insight and keen judgment from our senior lawyers and contract specialists who have collectively navigated thousands of transactions.
We can quickly recognize, prioritize, structure and document the key elements of every kind of transaction needed for our clients and their stakeholders to develop and commercialize new products.Our Firm is differentiated from other firms by:
- The depth of our expertise developed from our exclusive focus on providing transactional counsel to companies in the life sciences, cleantech, software, and in other industries based on new technologies;
- Our creative problem-solving and professional judgment based on the experiences that all of our senior lawyers have had working "in house" or as general counsel for pharmaceutical, technology and biotechnology companies (with legal, business development and/or executive management responsibilities); and
- Our ability to deliver extraordinary value because our billing rates are lower than rates for comparably experienced senior lawyers at "big box" law firms, we do not charge for any elements of our regular overhead, we staff efficiently, and we are extraordinarily sensitive to the application of cost-benefit analysis to our provision of legal services (because many of our professionals have been responsible for corporate legal budgets in the past).